Relay Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLAY and other ETFs, options, and stocks.About RLAY
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery.
CEOSanjiv K. Patel
CEOSanjiv K. Patel
Employees261
Employees261
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees261
Employees261
RLAY Key Statistics
Market cap616.34M
Market cap616.34M
Price-Earnings ratio-1.67
Price-Earnings ratio-1.67
Dividend yield—
Dividend yield—
Average volume1.29M
Average volume1.29M
High today$3.73
High today$3.73
Low today$3.56
Low today$3.56
Open price$3.68
Open price$3.68
Volume1.03M
Volume1.03M
52 Week high$10.72
52 Week high$10.72
52 Week low$1.78
52 Week low$1.78
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%
People also own
Based on the portfolios of people who own RLAY. This list is generated using Robinhood data, and it’s not a recommendation.